Cellyan Biotechnology Co., Ltd (HKPD) Return on equity 2024–2025
Cellyan Biotechnology Co., Ltd (HKPD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-0.5%FY2025 · since FY2024: 31.3% → -0.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -0.5% | -31.8 pp |
| FY2024 | 31.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice